Filing Details
- Accession Number:
- 0001415889-24-013657
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-17 21:58:30
- Reporting Period:
- 2024-05-15
- Accepted Time:
- 2024-05-17 21:58:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1656634 | Gritstone Bio Inc. | GRTS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1374539 | R Andrew Allen | C/O Gritstone Bio, Inc. 5959 Horton Street, Suite 300 Emeryville CA 94608 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-15 | 47,873 | $0.00 | 1,009,623 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-05-16 | 24,263 | $0.75 | 985,360 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-05-15 | 615,000 | $0.00 | 615,000 | $0.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 615,000 | 2034-05-14 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,449,275 | Indirect | See footnote |
Footnotes
- Represents Performance Stock Units ("PSUs") granted on March 22, 2024 that were earned by the Reporting Person as a result of the achievement of certain performance criteria as certified by the Issuer's Board of Directors on May 15, 2024. The PSUs vest over one year; 1/2 vested on May 15, 2024, and thereafter the remaining 1/2 will vest on May 15, 2025, subject to the continuing service of the Reporting Person on such vesting date. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock.
- Includes 870,362 Restricted Stock Units ("RSUs") and PSUs which are subject to vesting.
- The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of PSUs.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.735 to $0.7616 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The shares are held in the name of the Reporting Person's revocable trust of which the Reporting Person is a co-trustee. The Reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- The option vests as to 1/2 of the total grant on September 30, 2024, with the remainder of grant vesting on September 30, 2025, subject to the continued service of the Reporting Person on each vesting date.
Billionaire Hedge Funds
